App is temporarily unavailable
重症医路
Published by:
Zhejiang yunde technology co
Description
重症医路APP是针对于解决全科室重症难题，而开发的学术传播移动平台。
重症医路以重症为核心，铺陈了全面的应对办法，并分布在病例、文章、视频、课程、讨论专区等等版块资源中，满足不同医生对于不同难题的学术资源获取需求。
免责声明：该APP是一款专门面向医生群体开发的学术学习工具，用户在做任何医疗决定时，必须去专业的医疗机构寻求医生的建议，本APP不提供任何的医疗决定服务。
重症医路以重症为核心，铺陈了全面的应对办法，并分布在病例、文章、视频、课程、讨论专区等等版块资源中，满足不同医生对于不同难题的学术资源获取需求。
免责声明：该APP是一款专门面向医生群体开发的学术学习工具，用户在做任何医疗决定时，必须去专业的医疗机构寻求医生的建议，本APP不提供任何的医疗决定服务。
Screenshots
重症医路 FAQ
-
Is 重症医路 free?
Yes, 重症医路 is completely free and it doesn't have any in-app purchases or subscriptions.
-
Is 重症医路 legit?
Not enough reviews to make a reliable assessment. The app needs more user feedback.
Thanks for the vote -
How much does 重症医路 cost?
重症医路 is free.
-
What is 重症医路 revenue?
To get estimated revenue of 重症医路 app and other AppStore insights you can sign up to AppTail Mobile Analytics Platform.
User Rating
App is not rated in Hong Kong SAR China yet.
Ratings History
重症医路 Reviews
No Reviews in Hong Kong SAR China
App doesn't have any reviews in Hong Kong SAR China yet.
重症医路 Installs
Last 30 days
重症医路 Revenue
Last 30 days重症医路 Revenue and Downloads
Gain valuable insights into 重症医路 performance with our analytics.
Sign up now to access downloads, revenue, and more.
Sign up now to access downloads, revenue, and more.
App Info
- Category
- Medical
- Publisher
- Zhejiang yunde technology co
- Languages
- English
- Recent release
- 4.1.2 (2 years ago )
- Released on
- Apr 1, 2020 (4 years ago )
- Also available in
- China , Romania , South Korea , Kuwait , Kazakhstan , Lebanon , Malaysia , Nigeria , New Zealand , Peru , Philippines , Pakistan , Poland , Portugal , Italy , Russia , Sweden , Singapore , Thailand , Türkiye , Taiwan , Ukraine , United States , Vietnam , South Africa , Egypt , Australia , Azerbaijan , Belgium , Belarus , Chile , Czechia , Germany , Denmark , Dominican Republic , Algeria , Ecuador , Japan , Spain , Finland , France , United Kingdom , Greece , Hong Kong SAR China , Hungary , Indonesia , Ireland , India , Austria
- Last Updated
- 9 months ago
This page includes copyrighted content from third parties, shared solely for commentary and research in accordance with fair use under applicable copyright laws. All trademarks, including product, service, and company names or logos, remain the property of their respective owners. Their use here falls under nominative fair use as outlined by trademark laws and does not suggest any affiliation with or endorsement by the trademark holders.